Syra Health has secured multiple government contracts and completed a public offering, alongside leadership changes and financial reporting updates.

• Syra Health won a $5.8 million contract in Indiana to lead a child mental health access site, expanding its government service footprint [N1].
• The company was awarded a $1 million contract for healthcare services in Washington D.C., reinforcing its presence in public sector healthcare [N2].
• Syra Health received a healthcare workforce contract and contract extension, supporting its service offerings [N3].
• The company reported Q3 2024 EPS of $0.06 compared to a loss of $0.21 the prior year, indicating improved quarterly performance [N4].
• Syra Health priced a $2.1 million public offering of shares and warrants in September 2024, enhancing capital resources [N5].
• Syra Health serves as a subcontractor for Luke Air Force Base under the Defense Health Agency, diversifying its government contracts [N6].

Syra Health has demonstrated the ability to secure significant government contracts, including a $5.8 million contract in Indiana and a $1 million contract in Washington D.C., indicating operational capability and market acceptance. The appointment of an experienced CEO with a track record in healthcare growth and population health services may support strategic initiatives. The company's liquidity position with a strong current ratio and cash reserves provides operational flexibility. The equity incentive plan supports employee and leadership motivation, potentially aiding execution of growth strategies.

The company reported a net loss and negative earnings per share for the fiscal year ended 2025, indicating ongoing profitability challenges. Syra Health operates in a competitive healthcare services market with reliance on government contracts, which may be subject to renewal risks and funding uncertainties. The absence of disclosed market capitalization and limited public financial metrics may limit external visibility. Executive compensation and related party transactions require monitoring for governance and cost control. The company did not award annual bonuses in 2025, reflecting performance or financial constraints.

Syra Health's moat is based on its specialized contracts with government agencies and healthcare organizations in the population health and workforce services space. Its leadership's deep experience in Medicare Advantage and Medicaid markets, along with established relationships and contract awards, provide operational footholds. The company's equity incentive plan and governance structure support talent retention and strategic execution. However, the healthcare services sector is competitive and subject to regulatory and funding changes, which may impact contract renewals and growth.

• Contract Renewal and Funding Risk: Syra Health's business depends on government contracts which may not be renewed or may face funding cuts, impacting revenue stability.
• Profitability Challenges: The company reported net losses and negative EPS, indicating risks related to achieving sustained profitability.
• Competitive Market: The healthcare workforce and population health services market is competitive, with pressure on pricing and contract awards.
• Governance and Related Party Transactions: Leases and services with related parties require careful oversight to avoid conflicts of interest and ensure cost efficiency.

• Syra Health Corp is a Delaware corporation headquartered in Carmel, Indiana.
• The company operates in the healthcare sector with a focus on population health services, Medicare Advantage, and Medicaid markets.
• Gregory R. Alexander was appointed CEO effective January 5, 2026, bringing over two decades of leadership experience in healthcare and population health.
• Priya Prasad serves as CFO, COO, and director, with extensive leadership experience and involvement in technology and consulting companies.
• The board includes directors with backgrounds in pharmaceutical research, healthcare technology, and business process improvement.
• Syra Health provides healthcare workforce services and population health management, serving government and healthcare clients.
• The company has been awarded multiple contracts including a $5.8 million Indiana contract to lead a child mental health access site, a $1 million healthcare services contract in Washington D.C., and a healthcare workforce contract and extension.
• Syra Health serves as a subcontractor for the Defense Health Agency at Luke Air Force Base.
• The company reported revenue of approximately $7.23 million and a net loss of about $0.9 million for the fiscal year ended December 31, 2025.
• Basic and diluted EPS for 2025 were both negative $0.08 per share.
• As of December 31, 2025, Syra Health had cash and cash equivalents of approximately $1.61 million and current assets of about $2.74 million, with current liabilities of approximately $0.67 million, resulting in a current ratio of 4.06 and a cash ratio of 2.39.
• The company completed a $2.1 million public offering of shares and warrants in September 2024.
• No annual incentive bonuses were awarded to executives for 2025 based on company performance.
• The company leases its corporate headquarters under a lease agreement with related parties, with monthly rent adjustments through mid-2027.
• Syra Health has a 2022 Omnibus Equity Incentive Plan with over 1 million shares reserved for issuance, supporting employee and director incentives.
• The company is classified as a smaller reporting company and an emerging growth company under SEC definitions.